Anti-stress product market goes up by 16% during crisis

The anti-stress product market in the first nine months of this year advanced by 16.4%, to 1.33m euros, while in terms of units the increase was almost similar, of around 15.2%, to 0.6 million units, according to Cegedim Romania market research firm. The anti-stress product segment posted a better performance compared with the total market, which in the first nine months of this year fell by 3%, in euros, to 1.4bn euros. "I've recently witnessed a strong increase in both demand and supply of natural anti-stress products, most likely owing to the ever greater openness of patients to natural products, to a better education in this regard," said Roxana Petrovici, a specialist pharmacist with Fiterman Pharma producer, a major player on this market. She believes an uncovered segment on this market is that of anti-stress products for children, "a segment hard to tap into because of the limited range of natural ingredients that can be administered to small age groups". The main products on this market, which market research company Cegedim calls the market of herbal hypnotics and sedatives include Sedatif PC (Boiron), Persen (Novartis), Bien Dormir (Fiterman Pharma), Calmogen (GSK), Vagostabyl (Leurquin Mediolanum) or Relaxirem (Remedia).